Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Sampling and search for the EGFR mutation: what's taking, when and how to test?].

Revue de pneumologie clinique - 1 Jun 2011

Cadranel J, Giroux Leprieur E

Abstract excerpt

Since the IPASS study, that has shown a benefit in term of progression-free survival in first line of treatment in non-small cell lung cancer (NSCLC) with activating EGFR mutations, and the restricted prescription of this treatment to the presence of these mutations, the determination of the mutational status has became necessary at the diagnosis. This research study of these mutations, present in about 10% of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Biopsy
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Genes, erbB-1

Share to Lung Neoplasms

Share to Predictive Value of Tests

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 21777768
DOI: 10.1016/S0761-8417(11)70004-9

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Sampling and search for the EGFR mutation: what's taking, when and how to test?].PMID 21777768Read ↗

[Searching for EGFR: current practices].Semantic proximity Read ↗

[Which platform to support a personalized lung cancer treatment?].Semantic proximity Read ↗

[Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Pro].Semantic proximity Read ↗

[The detection methods of EGFR mutations in non-small cell lung cancer].Semantic proximity Read ↗

[Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Contra].Semantic proximity Read ↗

[Determination of EGFR gene somatic mutations in tissues and plasma of patients with advanced non-small cell lung cancer].Semantic proximity Read ↗

Epidermal growth factor receptor mutation study for 5 years, in a population of patients with non-small cell lung cancer.Semantic proximity Read ↗

[Mutation testing for non-small-cell lung cancer].Semantic proximity Read ↗

Targeted therapy in non-small cell lung cancer: a focus on epidermal growth factor receptor mutations.Semantic proximity Read ↗

The Detailed Analysis of Polish Patients with Non-Small Cell Lung Cancer Through Insights from Molecular Testing (POL-MOL Study).Semantic proximity Read ↗

Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?Semantic proximity Read ↗

Epidermal Growth Factor Recetor mutation study for 5 years, in a population of patients with non-small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.